Search
Movember
PCC Homepage
Prostate Cancer
What is the Prostate?
What is Prostate Cancer?
How Common is Prostate Cancer?
Causes and Risk Factors
Prevention
Symptoms
BPH
Prostatitis
Diagnosis
Early Detection
Digital Rectal Exam
PSA Test
Biopsy
Ultrasound
Clinical Testing and the Gleason Grade
CT Scan
Bone Scan
Treatment
Active Surveillance
Experimental and Alternative Therapies
Surgery
Laparoscopic Surgery
External Beam Radiation
Brachytherapy
Hormone Therapy
Chemotherapy
Complementary Therapies
Palliative Therapies
Recurrence/Metastases
Treating Recurrence
Hormone Resistant PCa
Life Beyond Cancer
Following Up
Lifestyle Changes
Diet
Exercise
Supplements
Stress Reduction
Managing Treatment Effects
Incontinence
Erectile Dysfunction
Infertility
Hormonal Changes
Bowel Problems
Confronting Stress
Anxiety
Depression
Recommended Readings
Books From Your Library or Bookstore
Free Information from PCCN
Multimedia
Support Groups
Find a Group Near You
British Columbia
The Prairies
Toronto & 905 Region
Ontario
Quebec
The Maritimes
Newfoundland & Labrador
Groups from Coast to Coast
Start a New Group
Contact Your Regional Rep
Add/Change Your Group Info
Join A Virtual Support Group
Discover What's New
Issues
Sustainability
About the Network
Advocacy
Donate
Privacy Policy
National Conference
2011 Information
2010 Information
2009 Information
2008 Information
2006 Information
Political Action
What We Do
Mailing List
News and Announcements
Newsletters
Archived CPCN Newsletters
PCCN Barrie (Man to Man)
PCCN Brampton
PCCN Calgary
PCCN Comox Valley
PCCN Durham Region
Kelowna
PCCN Newmarket
PCCN Markham
PCCN Montreal West Island
Newfoundland & Labrador (In Touch)
PCCN Ottawa
PCCN Owen Sound
PCCN Pictou County
PCCN Regina
PCCN Surrey
PCCN Toronto (Man to Man)
PCCN Winnipeg
Other Newsletters and Magazines
PCCN News
Our Voice
Resources
Links
Order Support Materials
In The News
Well-Done Meat Consumption May Increase Prostate Cancer Risk
Research into the dietary habits of about a thousand men from the Cleveland area has found that a high consumption of meats, especially of red meat prepared by grilling, is positively associated with an increased risk of developing aggressive prostate cancer. This particular study, which was led by Dr. John Witte of the University of California, San Francisco (UCSF), has a number of limitations, but it does add support to other investigations connecting meat consumption with cancer risk.
Toronto researchers speculate regarding a link between prostate cancer and oral contraceptive use
Very preliminary and speculative research, designed to spark further inquires, suggests that there may be a connection between oral contraceptive use and rising rates of prostate cancer. One theory is that the widespread use of birth-control pills in various populations may result in a higher level of estrogen in the environment, which might, in turn, increase prostate cancer risk.
Click For Information Archive
Incontinence
Urinary incontinence, or an inability to control urination, is a common side effect of prostate cancer surgery or radiation therapy. There are four types or categories of incontinence:
Urge incontinence:
This condition is sometimes called an “overactive bladder.” Men with urge incontinence experience a sudden need to urinate and cannot control that urge long enough to reach a toilet.
Overflow incontinence:
Men with overflow incontinence have difficulty emptying their bladders, so urine leaks out when their bladders are full. This condition is frequently caused by the obstruction of the bladder or by weak bladder muscles.
Stress incontinence:
A man with stress incontinence will experience urine leakage when he exerts himself, say by coughing or lifting something heavy. This condition can be caused by damage to the urethral sphincter, the name for the group of muscles that can close off the bladder and control urination.
Continuous incontinence:
Men with this very rare condition lose all ability to control their urine.
Why can prostate cancer treatment cause incontinence?
Simply put, the answer to this question is that, to cure prostate cancer, we need to remove or destroy prostate tissue. And the prostate surrounds the urethra, the tube that connects to the bladder and runs through the penis, allowing for the excretion of urine from the body. Prostate surgery, for example, removes the internal sphincter, which is contained within the neck of the bladder and the upper part of the urethra surrounded by the prostate. This removal makes the control of urination more dependent on the external sphincter---the muscle close to the pelvic floor that men can voluntarily contract to stop their urine flow. Consequently, stress incontinence is more likely. Another risk with prostate surgery is that scar tissue may form at the neck of the bladder where the bladder and urethra have been sewn back together after the removal of the prostate, causing overflow incontinence because of an obstruction. Radiation carries risk too, as it can decrease the capacity of the bladder and cause spasms that force urine out.
How common is it?
This question is difficult to answer because of the various degrees and types of incontinence. Also, some loss of bladder control occurs naturally as we age because our muscles lose their tone and flexibility. The Vancouver Prostate Centre reports the following:
Surgery (radical prostatectomy)
: Most men recover significant bladder control in about 12 weeks, although this control continues to improve over 1 to 2 years. Over 90 per cent achieve excellent urinary control and require no pads. Some men will continue to suffer mild stress incontinence, which does not appear to affect their quality of life, although some choose to wear pads for protection. About 1 to 2 per cent will have persistent, problematic incontinence.
Brachytherapy
: About 50 per cent of men will have moderate urinary obstruction or irritation, but, by 12 months, 90 per cent of men return to their pre-treatment state.
External Beam Radiation
: In about 90 per cent of men, the urge to urinate frequently or urinary incontinence clears up in about 6 weeks. The remaining 10 per cent will have more long-term or even permanent side effects, but these are mostly minor. Less than 1 per cent of men experience permanent and severe urinary incontinence because of external beam radiation.
What treatments are available?
Treatments depend on the type of incontinence and its severity.
Stress incontinence
is usually managed quite conservatively, at least initially. Your doctor may recommend that you wear protective pads or garments, make lifestyle and behavioural changes, and do pelvic floor exercises, commonly known as Kegel exercises.
Lifestyle or behavioural changes can help reduce stress incontinence. These include drinking fewer fluids, while ensuring that you do not become dehydrated; avoiding alcohol, caffeine, and spices; quitting smoking; urinating at regular intervals (or timed voiding) so as to keep the bladder fairly empty; or bladder training, which involves gradually training your bladder to hold more urine by resisting the urge to urinate. Losing weight may also help.
Pelvic floor exercises or Kegels work to strengthen the muscles that support the external urinary sphincter. These are the muscles you would contract so as to stop urinating in midstream. Often, getting a doctor or nurse to help you learn the proper technique is wise. And men sometimes combine Kegel exercise training with a biofeedback program. (For information on how to do Kegel exercises, consult the PCCN article
Recover Control Earlier with Exercise
or download the excellent article
Pelvic Muscle Exercises—Kegel Exercises
from the Canadian Continence Foundation.)
Urge incontinence
is frequently treated with medications called anitmuscarinics or anticholinergics or with bladder training:
Anticholinergics, such as oxybutynin (Ditropan, Ditropan XL, Uromax, Oxytrol), tolterodine (Detrol, Detrol LA), solifenacine (Vesicare), darifenacine (Enablex), and trospium chloride (Trosec), work by blocking the action of nerves that are not under conscious control. So they can help prevent the contractions of the bladder that cause urge incontinence. By relaxing the bladder, they also increase its capacity; so they reduce urinary frequency as well as urgency.
Bladder training involves resisting the urge to urinate, for an ever-increasing number of minutes, so as to train your bladder to hold more urine.
Slightly more bothersome
stress and urge incontinence
can be treated with the following:
Biofeedback instruction offered by health care professionals: This process uses mechanical or electronic equipment to give you feedback regarding how well you are using your pelvic floor muscles.
Electrical stimulation: This process involves stimulating the nerves that control the bladder so that they contract and you learn how to operate these muscles correctly on your own.
For those men bothered by persistent or severe incontinence, more aggressive treatments are available, for example, the artificial sphincter, the male sling, injections, and balloons.
An artificial urinary sphincter
(AUS) is the “gold standard” treatment for men with persistent and bothersome urinary stress incontinence. Usually, the AUS is made of three parts: a pump inserted into the scrotum, a cuff that surrounds the urinary canal, and a balloon reservoir placed behind the pubic bone. The entire system is filled with fluid and is implanted in the body. (No parts are visible after the surgery to implant the AUS.) When a man wants to urinate, he squeezes the pump, which is underneath the skin of the scrotum, and this moves fluid out of the cuff and into the balloon reservoir---thus opening the cuff and allowing urine through. The cuff then fills back up naturally, restoring urinary control. According to the Canadian Continence Foundation, approximately 80 per cent of the men who have received this treatment for incontinence are satisfied with the results. For more information, consult an article by PCCN member Doug Scott about his experiences with an AUS:
A Device to Restore Urinary Continence after Prostate Cancer Treatment
.
The male sling
is usually made of a mesh material, which is surgically implanted under the middle part of the urethra. The sling reinforces the urethra and, when downward force is applied, say because of a laugh, it provides support beneath the urethra that helps it contract and stop leakage. Because the sling is placed loosely, when there is no downward pressure, it doesn’t obstruct the urine flow. Slings may not be available in all areas, and there is less long-term data on the male sling than on the AUS. Also, for men who have had radiotherapy, the sling may be less effective than the artificial sphincter.
Injection therapy
involves injecting material (often collagen) just under the lining of the urethra to “bulk” it up and cause it to close inward on itself, creating a sort of seal in the process. This therapy is not usually a good option for men after prostate cancer treatment. Scar tissue may make the selection of appropriate injection sites tricky, and the benefits are often short-lived because the injected material can be reabsorbed into the body.
Adjustable continence therapy
, which uses
balloon implants
, is a relatively new therapy for stress incontinence, and it may not be available in all areas. Balloon implants are positioned at the neck of the bladder, and, after they are in place, the amount of fluid in them can be adjusted through injecting or withdrawing fluid via small ports just under the skin of the scrotum. (These ports are connected by tubing to the balloon implants.) The balloons act as a sort of valve, reinforcing the neck of the bladder and helping men to establish urinary control.
For more information, consult the
Canadian Continence Foundation
website. Especially useful, are these sections of the website:
Newsletters & Documents
Incontinence Learning Presentations
Did you know? Rates of prostate cancer in men are comparable to rates of breast cancer in women. #1in7men.
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Receive updates and be the first to find out what's new at PCC.
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital